valyl-glycyl-valyl-alanyl-prolyl-glycine has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skóra, B; Szychowski, KA; Tabęcka-Łonczyńska, A | 1 |
| Gmiński, J; Szychowski, KA | 1 |
2 other study(ies) available for valyl-glycyl-valyl-alanyl-prolyl-glycine and Inflammation
| Article | Year |
|---|---|
Calcium channel antagonists interfere with the mechanism of action of elastin-derived peptide VGVAPG in mouse cortical astrocytes in vitro.
Topics: Animals; Astrocytes; Calcium Channel Blockers; Dizocilpine Maleate; Elastin; Humans; Inflammation; Mice; Neuroblastoma; Nifedipine; Oligopeptides; Peptides; PPAR gamma; Reactive Oxygen Species; Superoxide Dismutase-1; Verapamil | 2022 |
The Elastin-Derived Peptide VGVAPG Does Not Activate the Inflammatory Process in Mouse Cortical Astrocytes In Vitro.
Topics: Animals; Astrocytes; Elastin; Gene Expression; Inflammation; Inflammation Mediators; Mice; Oligopeptides; Peptides; Primary Cell Culture; Rosiglitazone | 2020 |